"Liver Cirrhosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Descriptor ID |
D008103
|
| MeSH Number(s) |
C06.552.630
|
| Concept/Terms |
Liver Cirrhosis- Liver Cirrhosis
- Cirrhosis, Liver
- Cirrhoses, Liver
- Liver Cirrhoses
- Hepatic Cirrhosis
- Cirrhoses, Hepatic
- Cirrhosis, Hepatic
- Hepatic Cirrhoses
|
Below are MeSH descriptors whose meaning is more general than "Liver Cirrhosis".
Below are MeSH descriptors whose meaning is more specific than "Liver Cirrhosis".
This graph shows the total number of publications written about "Liver Cirrhosis" by people in this website by year, and whether "Liver Cirrhosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 4 | 0 | 4 |
| 2001 | 0 | 1 | 1 |
| 2002 | 4 | 1 | 5 |
| 2003 | 5 | 2 | 7 |
| 2004 | 4 | 0 | 4 |
| 2005 | 4 | 2 | 6 |
| 2006 | 6 | 2 | 8 |
| 2007 | 4 | 2 | 6 |
| 2008 | 5 | 0 | 5 |
| 2009 | 2 | 0 | 2 |
| 2010 | 5 | 2 | 7 |
| 2011 | 5 | 3 | 8 |
| 2012 | 3 | 3 | 6 |
| 2013 | 7 | 3 | 10 |
| 2014 | 9 | 3 | 12 |
| 2015 | 6 | 3 | 9 |
| 2016 | 11 | 3 | 14 |
| 2017 | 7 | 3 | 10 |
| 2018 | 10 | 2 | 12 |
| 2019 | 15 | 5 | 20 |
| 2020 | 8 | 4 | 12 |
| 2021 | 6 | 10 | 16 |
| 2022 | 2 | 8 | 10 |
| 2023 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver Cirrhosis" by people in Profiles.
-
Improved Mortality But Increased Economic Burden of Disease in Compensated and Decompensated Cirrhosis: A US National Perspective. J Clin Gastroenterol. 2023 03 01; 57(3):300-310.
-
Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis. Aliment Pharmacol Ther. 2023 Mar; 57(5):454-463.
-
Identifying Patients at Risk for Fibrosis in a Primary Care NAFLD Cohort. J Clin Gastroenterol. 2023 Jan 01; 57(1):89-96.
-
An AI Approach for Identifying Patients With Cirrhosis. J Clin Gastroenterol. 2023 Jan 01; 57(1):82-88.
-
The role of complement in nonalcoholic fatty liver disease. Front Immunol. 2022; 13:1017467.
-
The role of dietary factors in nonalcoholic fatty liver disease to hepatocellular carcinoma progression: A systematic review. Clin Nutr. 2022 10; 41(10):2295-2307.
-
Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials. Clin Gastroenterol Hepatol. 2023 03; 21(3):723-731.e9.
-
FIB-4 and incident severe liver outcomes in patients with undiagnosed chronic liver disease: A Fine-Gray competing risk analysis. Liver Int. 2023 01; 43(1):170-179.
-
Imaging Mass Spectrometry Reveals Alterations in N-Linked Glycosylation That Are Associated With Histopathological Changes in Nonalcoholic Steatohepatitis in Mouse and Human. Mol Cell Proteomics. 2022 05; 21(5):100225.
-
Bleeding ectopic varices: clinical presentation, natural history, and outcomes. J Investig Med. 2022 06; 70(5):1280-1284.